One Molecule, Three Patients: Why H₂ Water Works Differently
Picture three people holding the same glass of hydrogen water. One had two stents placed after a heart attack last spring. One is six months past an ischemic stroke. One is a 29-year-old who has had three heart surgeries since birth for a congenital heart condition.
The molecule in each glass is identical. The question each person should ask about it is not.
Here is the short answer. Molecular hydrogen (H₂) is studied as a selective antioxidant that targets the most reactive free radicals. Research looks different across heart attack, stroke and congenital heart patients because oxidative injury occurs in different organs and the evidence base differs in size. Most human trials used inhaled hydrogen, not drinking water, so hydrogen water is best viewed as antioxidant support, not treatment.
This article walks through all three cases honestly: what is known, what is promising, and what is still unproven. That honesty matters more with hydrogen than with most nutrients, because this is a field where marketing has often run ahead of the science.
简短的答案： 想象三个人手里拿着同一杯氢水：一位去年春天心梗后放了两个支架；一位缺血性脑卒中后六个月；一位 29 岁、自出生起因先天性心脏病做过三次手术。
杯中的分子完全相同，但每个人应该问的问题并不相同。
分子氢（H₂）被作为一种「选择性抗氧化物质」研究，主要针对最具破坏性的自由基。它在三类患者中的研究面貌不同，是因为氧化损伤发生在不同器官，证据规模也不同。大多数人体试验使用的是吸入氢气而非饮用氢水，因此氢水最适合被视为抗氧化支持，而非治疗。
本文将诚实地讲清三种情况：哪些已知、哪些有前景、哪些尚未证实——在氢这个营销常常跑在科学前面的领域，这种诚实尤其重要。
What is molecular hydrogen, and why is it called a selective antioxidant?
Hydrogen gas is the smallest molecule there is, with a molecular weight of about 2 daltons. It is tasteless, odourless and, at the concentrations found in hydrogen water, non-toxic.
Interest in hydrogen as a biological molecule took off in 2007, when researchers in Japan reported in Nature Medicine that hydrogen selectively neutralised the hydroxyl radical (·OH) and peroxynitrite, two of the most destructive reactive species in the body, while leaving milder reactive oxygen species largely untouched (Ohsawa et al., Nature Medicine, 2007). In the same paper, inhaled hydrogen reduced brain injury in rats after interrupted blood flow.
Why does "selective" matter? Not all free radicals are harmful. Some, such as hydrogen peroxide in small amounts, act as signals the body uses for normal functions, including adapting to exercise and fighting infection. Very strong, broad antioxidants may blunt those useful signals. The hydroxyl radical, by contrast, has no known useful role; it simply damages whatever it touches, including DNA, proteins and cell membranes. A molecule that targets mainly the worst offender is an appealing idea.
Because it is so small, hydrogen also diffuses easily through cell membranes and into compartments, such as mitochondria and, in animal studies, the brain, that larger antioxidant molecules struggle to reach.
什么是分子氢？为什么称它为「选择性」抗氧化物质？
氢气是最小的分子，分子量约 2 道尔顿，无色无味，在氢水的浓度下无毒。
2007 年，日本研究者在《自然·医学》发表研究：氢能选择性中和羟自由基（·OH）和过氧亚硝酸盐这两种体内最具破坏性的活性物质，而对较温和的活性氧影响很小；同一研究中，吸入氢气减轻了大鼠脑缺血后的损伤。
「选择性」为什么重要？并非所有自由基都有害，少量过氧化氢等是身体用于适应运动、抵抗感染的信号分子，过强的广谱抗氧化剂可能削弱这些有益信号。而羟自由基没有已知的有益作用，只会损伤 DNA、蛋白质和细胞膜。一种主要针对「最坏的那个」的分子，自然引人关注。
由于极小，氢也容易穿过细胞膜，进入线粒体等大分子抗氧化剂难以到达的区域；动物研究中还观察到它可进入大脑。
The shared starting point: oxidative stress when blood flow returns
All three patients in our example share one biological event. When tissue loses its blood supply and then gets it back, the sudden return of oxygen triggers a burst of free radicals. This is ischemia-reperfusion injury. It happens in heart muscle when a blocked coronary artery is reopened, in the brain when a clot is removed or dissolves, and in the heart during open surgery on the heart-lung machine.
Reperfusion is always the right goal; restoring blood flow saves tissue. But the oxidative burst that comes with it is one reason researchers have looked for antioxidants that can act quickly and reach the right places. That shared mechanism is also the reason the three patient groups diverge: the organ, the timing and the strength of the evidence are different in each case.
共同的起点：血流恢复时的氧化应激： 三位患者共享同一个生物事件：组织失去血供后再恢复，氧气骤然回流会引发自由基爆发，即「缺血-再灌注损伤」。它发生在冠脉重新打通时的心肌、血栓被取出或溶解后的大脑，以及体外循环下开胸手术时的心脏。
恢复血流永远是正确的目标，因为它能挽救组织；但随之而来的氧化爆发，正是研究者寻找能快速起效、到达正确位置的抗氧化物质的原因之一。这一共同机制也解释了三类患者为何分化：器官不同、时机不同、证据强度也不同。
Heart attack and stent patients: where the research is most direct
For people who have had a heart attack treated with a stent, the link between hydrogen and reperfusion injury has been tested in the most clinically relevant setting. Numerous animal studies of cardiac ischemia-reperfusion have reported smaller areas of damaged heart muscle with hydrogen, a body of work reviewed by Kura and Slezak in 2024 (International Journal of Molecular Sciences).
In humans, a small pilot study in Japan gave inhaled hydrogen to patients with ST-elevation heart attacks during stenting and reported favourable changes in heart remodelling at six months (Katsumata et al., Circulation Journal, 2017). It was a pilot, not a definitive trial, and it used hydrogen gas at the time of the procedure.
What this means for you: the reperfusion window during the heart attack itself has passed. Hydrogen water afterwards is not a treatment for heart damage. The reasonable framing is general antioxidant support during the months when inflammation and oxidative stress are settling, alongside the medications that protect your arteries.
心梗与支架患者：研究最直接的领域：
对于接受支架治疗的心梗患者，氢与再灌注损伤的关系在最贴近临床的场景中被研究过。大量心脏缺血-再灌注动物研究报告，使用氢后受损心肌面积更小（Kura 与 Slezak 2024 年综述，《国际分子科学杂志》）。
人体方面，日本一项小型试点研究在 ST 段抬高型心梗患者支架术中给予吸入氢气，报告 6 个月时心脏重构指标有利变化（《循环杂志》2017）——这是试点研究而非确证性试验，且使用的是术中氢气。
对你意味着什么：心梗发作时的再灌注窗口已经过去，术后饮用氢水不是心肌损伤的治疗。合理的定位是：在炎症和氧化应激逐渐平息的数月中，作为一般性抗氧化支持，与保护血管的药物并行。
Stroke survivors: why crossing into the brain matters
The brain is especially vulnerable to oxidative damage. It uses a large share of the body's oxygen, is rich in fats that oxidise easily, and has relatively modest antioxidant defences. It is also protected by the blood-brain barrier, which keeps out many substances, including many antioxidants. Hydrogen's tiny size is the reason stroke researchers are interested in it.
The human evidence is still early. A randomised study of about 50 patients with acute cerebral infarction found inhaled hydrogen to be safe and reported improvements on some neurological and imaging measures (Ono et al., Journal of Stroke and Cerebrovascular Diseases, 2017). A multicentre randomised trial in Japan gave inhaled hydrogen to patients after cardiac arrest, a situation involving whole-brain ischemia, and reported better neurological recovery at 90 days, though the trial was stopped early and was small (Tamura et al., HYBRID II, eClinicalMedicine, 2023).
What this means for you: these findings are promising and explain why hydrogen is discussed more for stroke than for most conditions. But they come from inhaled hydrogen in the acute phase. For stroke survivors months later, hydrogen water is best seen as antioxidant support within a broader brain-recovery plan that includes blood pressure control, rehabilitation, sleep and nutrition. Stroke recovery also has distinct nutritional priorities, covered in why cardiac and stroke recovery nutrition differ.
脑卒中幸存者：为什么「进入大脑」很重要：
大脑特别容易受氧化损伤：它消耗全身大量氧气、富含易氧化的脂肪、抗氧化防御相对有限，还受血脑屏障保护，许多物质（包括很多抗氧化剂）无法进入。氢的极小体积正是卒中研究者关注它的原因。
人体证据仍处早期：一项约 50 名急性脑梗死患者的随机研究显示吸入氢气安全，并在部分神经和影像指标上有改善（2017）；日本一项多中心随机试验对心脏骤停后（全脑缺血）患者给予吸入氢气，报告 90 天神经恢复更好，但试验规模小且提前终止（HYBRID II，2023）。
对你意味着什么：这些发现有前景，也解释了为什么氢在卒中领域讨论更多；但它们来自急性期吸入氢气。对于数月后的卒中幸存者，氢水更适合作为更广泛脑康复计划中的抗氧化支持，该计划还应包括血压控制、康复训练、睡眠和营养。
Adults with congenital heart disease: the thinnest evidence
Here honesty requires saying the least. There are no dedicated clinical trials of hydrogen in adults with congenital heart disease. The rationale is indirect: repeated surgeries, time on the heart-lung machine, and in some conditions long-term low oxygen levels or chronic low-grade inflammation, all of which involve oxidative stress.
That makes hydrogen water, at most, a general antioxidant support option to discuss with your ACHD team. There is also a practical safety issue that matters more for this group than for most: some people with congenital heart disease, including many with a Fontan circulation or heart failure, are on a fluid limit. Every glass of hydrogen water counts towards that limit. Ask your team before adding any regular drink to your day.
先天性心脏病成人：证据最薄弱： 这里诚实意味着说得最少。目前没有专门针对成人先心病患者的氢临床试验，理论依据是间接的：多次手术、体外循环，以及部分病情中的长期低氧或慢性低度炎症，都涉及氧化应激。
因此，氢水至多是一种可与 ACHD 团队讨论的一般性抗氧化支持选项。对这一群体还有一个格外重要的安全问题：部分先心病患者（包括很多 Fontan 循环或心衰患者）需要限制液体摄入，每一杯氢水都计入限额。在日常加入任何规律饮品前，请先询问你的医疗团队。
Hydrogen water vs inhaled hydrogen: why the delivery method matters
This is the most important nuance in the whole topic, and the one most often left out. The dose of hydrogen a person receives from inhaling a few percent hydrogen gas for an hour is very different from what arrives in a glass of water.
Water can hold only about 1.6 parts per million of hydrogen at room temperature and normal pressure, and the gas escapes quickly once a container is opened. Hydrogen from drinking water is absorbed and exhaled within a relatively short time. Studies of hydrogen-rich water in humans do exist, mostly in other conditions, but they tend to be small and short.
For readers, that leads to three practical points. First, results from inhalation trials should not be quoted as if they were hydrogen water results. Second, if you use hydrogen water, freshness matters: drink it soon after it is made or opened. Third, some hydrogen tablets work by reacting magnesium with water, which leaves magnesium in the drink. Magnesium is often useful for heart patients, but people with kidney disease or on certain medications should check with their doctor or pharmacist first.
氢水与吸入氢气：为什么给药方式很重要： 这是整个话题中最重要、也最常被省略的细节。
吸入几个百分点浓度的氢气一小时，与一杯水中获得的氢剂量差别很大。常温常压下水最多只能溶解约 1.6 ppm 的氢，开封后很快逸出；饮用后氢在较短时间内被吸收并呼出。人体氢水研究确实存在，但多数针对其他疾病，且规模小、周期短。
由此得出三点实用建议：一，不应把吸入试验结果当作氢水结果引用；二，如果饮用氢水，新鲜度很重要，制备或开封后尽快饮用；三，部分氢片通过镁与水反应产氢，饮品中会留有镁——镁对心脏病患者常有益，但肾病患者或服用某些药物者应先咨询医生或药剂师。
Where hydrogen water fits in a recovery plan
In the Healos™ 91-Day Root Repair Protocol, hydrogen water belongs to the first 30 days, which focus on reducing oxidative load before the protocol moves on to replacing nutrients commonly affected by surgery and medications, and then to supporting the body's own repair. The logic is sequencing: calm the oxidative environment first, then rebuild.
Its role there is specific and limited. Hydrogen water provides antioxidant support. It does not treat ischemia, heart damage or stroke, and it does not replace any medication. It works best as one part of a plan that also addresses sleep, movement, mood and medication adherence, the factors that explain why many people still feel unwell after a successful procedure. The timing logic behind the three stages is covered in the 91-day cellular renewal window.
氢水在康复计划中的位置： 在 Healos™ 91 天底层修复方案中，氢水属于前 30 天，重点是先降低氧化负荷，之后方案才进入补充手术和药物常影响的营养素、再支持身体自身修复的阶段。其逻辑在于顺序：先平息氧化环境，再进行重建。
它在这里的角色具体而有限：氢水提供抗氧化支持，不治疗缺血、心肌损伤或卒中，也不替代任何药物。它最适合作为整体计划的一部分，与睡眠、运动、情绪和服药依从性一起被管理——这些因素正解释了为什么很多人在成功手术后仍感到不适。
Is hydrogen water safe with heart and stroke medications?
In published human studies, hydrogen has had a good safety record, and no significant interactions with common cardiovascular drugs such as antiplatelets, anticoagulants, statins or blood pressure medications have been reported. That said, the studies are small, so the practical cautions are about the situation rather than the molecule: fluid limits in heart failure, Fontan circulation or kidney disease; magnesium content in tablet-based products; and the general rule of telling your care team and pharmacist about anything you add.
氢水与心脏、卒中药物同用安全吗？
已发表的人体研究中，氢的安全记录良好，未报告与抗血小板药、抗凝药、他汀或降压药等常见心血管药物有显著相互作用。但由于研究规模较小，实际需要注意的更多是个人情况而非分子本身：心衰、Fontan 循环或肾病的液体限制；片剂类产品中的镁含量；以及任何新增产品都应告知医疗团队和药剂师这一基本原则。
The bottom line
One molecule, three patients, three different questions. For heart attack and stent patients, the research is most direct but centred on the moment of reperfusion. For stroke survivors, hydrogen's ability to reach the brain makes it genuinely interesting, but human evidence is early and mostly inhaled. For adults with congenital heart disease, the rationale is indirect and fluid limits come first. In every case, hydrogen water is a form of antioxidant support that sits alongside medical care, not a replacement for it.
结论： 同一个分子，三类患者，三个不同的问题。
对心梗和支架患者，研究最直接，但集中在再灌注那一刻；对卒中幸存者，氢进入大脑的能力确实值得关注，但人体证据尚早，且多为吸入；对先心病成人，理论依据是间接的，液体限制优先。
在所有情况下，氢水都是与医疗并行的抗氧化支持，而不是替代。
Frequently asked questions
Does hydrogen water help after a heart attack or stent? Animal studies and a small human pilot using inhaled hydrogen during stenting suggest hydrogen may reduce reperfusion injury. After the procedure, hydrogen water can be considered general antioxidant support, not a treatment for heart damage, and it does not replace cardiac medications.
Is hydrogen water good for stroke recovery? Hydrogen can cross into the brain, and small trials of inhaled hydrogen in acute stroke and after cardiac arrest have shown promising results. Evidence for drinking hydrogen water in stroke recovery is limited, so it is best viewed as antioxidant support within a broader rehabilitation plan.
What is the difference between hydrogen water and inhaled hydrogen? Inhaled hydrogen gas delivers a larger, sustained dose and is what most clinical trials used. Hydrogen water contains only about 1.6 parts per million of hydrogen at most, and the gas escapes quickly once opened. Results from inhalation studies should not be assumed to apply to hydrogen water.
Is hydrogen water safe with heart and stroke medications? No significant interactions with common cardiovascular medications have been reported in published studies. The main cautions are fluid limits in heart failure, Fontan circulation or kidney disease, and magnesium content in tablet-based products. Tell your care team and pharmacist before starting.
Can adults with congenital heart disease drink hydrogen water? There are no dedicated studies in adults with congenital heart disease. Many ACHD patients have fluid limits, so every glass counts. Discuss it with your ACHD team before adding hydrogen water to your routine.
常见问题：
心梗或支架术后氢水有帮助吗？动物研究和一项术中吸入氢气的小型人体试点提示氢可能减轻再灌注损伤；术后氢水可视为一般性抗氧化支持，不是心肌损伤的治疗，也不替代心脏药物。
氢水对卒中康复有好处吗？氢能进入大脑，急性卒中和心脏骤停后的小型吸入试验结果有前景，但饮用氢水用于卒中康复的证据有限，宜视为康复计划中的抗氧化支持。
氢水和吸入氢气有何区别？吸入氢气剂量更大、更持续，是多数临床试验采用的方式；氢水最多约含 1.6 ppm，开封后迅速逸出，吸入研究结果不能直接套用到氢水。
与心脏和卒中药物同用安全吗？已发表研究未报告与常见心血管药物的显著相互作用，主要注意事项是心衰、Fontan 循环或肾病的液体限制，以及片剂产品的镁含量，开始前请告知医疗团队和药剂师。
先心病成人可以喝氢水吗？目前没有针对成人先心病的专门研究，很多 ACHD 患者需限制液体，每一杯都计入，开始前请与 ACHD 团队讨论。
References
Ohsawa I, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nature Medicine. 2007;13(6):688–694.
Kura B, Slezak J. The protective role of molecular hydrogen in ischemia/reperfusion injury. International Journal of Molecular Sciences. 2024.
Katsumata Y, et al. The effects of hydrogen gas inhalation on adverse left ventricular remodeling after percutaneous coronary intervention for ST-elevated myocardial infarction: first pilot study in humans. Circulation Journal. 2017;81(7):940–947.
Ono H, et al. Hydrogen gas inhalation treatment in acute cerebral infarction: a randomized controlled clinical study on safety and neuroprotection. Journal of Stroke and Cerebrovascular Diseases. 2017;26(11):2587–2594.
Tamura T, et al. Efficacy of inhaled hydrogen on neurological outcome following brain ischaemia during post-cardiac arrest care (HYBRID II): a multi-centre, randomised, double-blind, placebo-controlled trial. eClinicalMedicine. 2023;58:101907.
